Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ORIC
ORIC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORIC News
US Stocks Close Higher Amid Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Shares Plunge 28% Amid Safety Concerns
Apr 01 2026
stocktwits
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Reports New Rinzimetostat Developments
Apr 01 2026
NASDAQ.COM
ORIC Pharmaceuticals Shares Drop After Rinzimetostat Trial Data Release
Apr 01 2026
seekingalpha
ORIC Pharmaceuticals Faces Safety Concerns in Drug Trial
Apr 01 2026
stocktwits
ORIC Pharmaceuticals to Report New Drug Trial Data
Mar 27 2026
Newsfilter
BETA Technologies Reports Disappointing Q4 Results
Mar 09 2026
Benzinga
Lisata Therapeutics to be Taken Private by Kuva Labs
Mar 09 2026
Benzinga
U.S. Stock Futures Decline as Methanex Reports Disappointing Earnings
Mar 06 2026
Benzinga
ORIC Pharmaceuticals Reports Narrower Q4 Loss
Feb 24 2026
NASDAQ.COM
ORIC Pharmaceuticals Q4 2025 Financial Highlights
Feb 23 2026
seekingalpha
Oncolytics Biotech Accelerates Cancer Treatment with New Executive Appointments
Jan 14 2026
Newsfilter
Oncolytics Biotech Accelerates Cancer Treatment Progress, Aiming for FDA Approval in 2026
Jan 14 2026
PRnewswire
ORIC Pharmaceuticals to Present Drug Developments at 44th J.P. Morgan Healthcare Conference
Jan 06 2026
Globenewswire
Show More News
